Financial results - LOTUS PHARMEDICALS SRL

Financial Summary - Lotus Pharmedicals Srl
Unique identification code: 2205118
Registration number: J24/1673/1991
Nace: 4645
Sales - Ron
341.539
Net Profit - Ron
30.098
Employee
4
The most important financial indicators for the company Lotus Pharmedicals Srl - Unique Identification Number 2205118: sales in 2023 was 341.539 euro, registering a net profit of 30.098 euro and having an average number of 4 employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor cosmetice si de parfumerie having the NACE code 4645.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Lotus Pharmedicals Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 461.079 418.467 486.927 431.265 362.740 364.245 391.786 339.827 348.184 341.539
Total Income - EUR 462.792 424.174 491.232 434.558 366.349 365.592 395.656 341.610 351.635 342.984
Total Expenses - EUR 395.571 387.614 406.270 365.410 314.609 318.155 353.225 279.889 293.515 309.463
Gross Profit/Loss - EUR 67.221 36.560 84.962 69.149 51.740 47.437 42.431 61.721 58.120 33.521
Net Profit/Loss - EUR 56.171 28.897 71.368 64.434 48.108 43.792 38.513 58.322 54.629 30.098
Employees 8 7 7 8 7 6 6 4 0 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -1.6%, from 348.184 euro in the year 2022, to 341.539 euro in 2023. The Net Profit decreased by -24.365 euro, from 54.629 euro in 2022, to 30.098 in the last year.

Check the financial reports for the company - Lotus Pharmedicals Srl

Rating financiar

Financial Rating -
Lotus Pharmedicals Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Lotus Pharmedicals Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Lotus Pharmedicals Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Lotus Pharmedicals Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Lotus Pharmedicals Srl - CUI 2205118

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 70.368 66.957 62.468 60.451 56.181 52.151 48.277 44.619 42.156 39.457
Current Assets 440.061 393.765 428.980 416.867 393.254 385.376 379.157 398.254 409.693 376.713
Inventories 131.405 126.154 103.340 99.745 114.973 88.225 118.705 153.050 111.060 81.778
Receivables 246.254 230.070 228.162 222.477 204.876 173.925 202.613 187.926 218.084 155.926
Cash 62.402 37.541 97.478 94.645 73.405 123.225 57.839 57.278 80.549 139.009
Shareholders Funds 406.069 438.355 476.265 461.397 436.986 424.273 411.184 421.824 419.810 393.221
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 104.360 22.367 15.183 15.921 12.449 13.253 16.249 21.050 32.039 22.949
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4645 - 4645"
CAEN Financial Year 4645
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 376.713 euro in 2023 which includes Inventories of 81.778 euro, Receivables of 155.926 euro and cash availability of 139.009 euro.
The company's Equity was valued at 393.221 euro, while total Liabilities amounted to 22.949 euro. Equity decreased by -25.315 euro, from 419.810 euro in 2022, to 393.221 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Lotus Pharmedicals Srl

Comments - Lotus Pharmedicals Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.